{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T23:18:36Z","timestamp":1768864716031,"version":"3.49.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.clbc.2023.05.002","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T22:41:35Z","timestamp":1684363295000},"page":"598-619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Factors Associated With Guideline-Concordant Pharmacological Treatment for Neuropathic Pain Among Breast Cancer Survivors"],"prefix":"10.1016","volume":"23","author":[{"given":"Mrinmayee","family":"Lakkad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsey","family":"Dayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob T.","family":"Painter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2023.05.002_bib0001","doi-asserted-by":"crossref","unstructured":"Goucke CR. Essentials of interventional cancer pain management, 1st Ed.; 2019. doi:10.1213\/ane.0000000000004450","DOI":"10.1213\/ANE.0000000000004450"},{"issue":"7","key":"10.1016\/j.clbc.2023.05.002_bib0002","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1526-4637.2010.00880.x","article-title":"Pain in long-term breast cancer survivors: frequency, severity, and impact","volume":"11","author":"Jensen","year":"2010","journal-title":"Pain Med"},{"key":"10.1016\/j.clbc.2023.05.002_bib0003","unstructured":"Breast cancer survival rates: by stage, demographics, and more. Available at: https:\/\/www.healthline.com\/health\/breast-cancer\/survival-facts-statistics#improving-outlook. Accessed November 1, 2020."},{"issue":"SUPPL 3","key":"10.1016\/j.clbc.2023.05.002_bib0004","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pain.2010.10.010","article-title":"Chronic treatment-related pain in cancer survivors","volume":"152","author":"Paice","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.clbc.2023.05.002_bib0005","unstructured":"Female breast cancer \u2014 cancer stat facts. Available at: https:\/\/seer.cancer.gov\/statfacts\/html\/breast.html. Accessed August 13, 2020."},{"key":"10.1016\/j.clbc.2023.05.002_bib0006","series-title":"From Cancer Patient to Cancer Survivor: Lost in Transition: An American Society of Clinical Oncology and Institute of Medicine Symposium","year":"2006"},{"issue":"4","key":"10.1016\/j.clbc.2023.05.002_bib0007","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/2049463714542605","article-title":"Farquhar-Smith P. Pain in cancer survivors","volume":"8","author":"Brown","year":"2014","journal-title":"Br J pain"},{"issue":"4","key":"10.1016\/j.clbc.2023.05.002_bib0008","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1053\/sonu.2001.27914","article-title":"Late effects of cancer and its treatment","volume":"17","author":"Ganz","year":"2001","journal-title":"Semin Oncol Nurs"},{"issue":"16","key":"10.1016\/j.clbc.2023.05.002_bib0009","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1200\/JCO.2013.52.4629","article-title":"Pain in cancer survivors","volume":"32","author":"Glare","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2023.05.002_bib0010","unstructured":"Portenoy RK. Cancer pain management. Vol. 20.; 1993."},{"issue":"4","key":"10.1016\/j.clbc.2023.05.002_bib0011","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/15360288.2012.734908","article-title":"Chronic pain in cancer survivors: a growing issue","volume":"26","author":"Van Den Beuken-Van Everdingen","year":"2012","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"10.1016\/j.clbc.2023.05.002_bib0012","unstructured":"IASP terminology - IASP. Available at: https:\/\/www.iasp-pain.org\/terminology?navItemNumber=576#Pain. Accessed June 2, 2020."},{"issue":"1-2","key":"10.1016\/j.clbc.2023.05.002_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3959(03)00241-0","article-title":"Neuropathic pain following breast cancer surgery: proposed classification and research update","volume":"104","author":"Jung","year":"2003","journal-title":"Pain"},{"issue":"8 Suppl","key":"10.1016\/j.clbc.2023.05.002_bib0014","article-title":"Utility of the SEER-medicare data to identify chemotherapy use","volume":"40","author":"Warren","year":"2002","journal-title":"Med Care"},{"issue":"8","key":"10.1016\/j.clbc.2023.05.002_bib0015","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrd3226","article-title":"Pain market","volume":"9","author":"Melnikova","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.clbc.2023.05.002_bib0016","unstructured":"The joint commission's pain standards\u2014origins and evolution \u2014CERGM. Available at: https:\/\/cergm.carter-brothers.com\/2019\/03\/07\/the-joint-commissions-pain-standards-origins-and-evolution\/. Accessed August 15, 2020."},{"issue":"27","key":"10.1016\/j.clbc.2023.05.002_bib0017","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.2016.68.5206","article-title":"Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline","volume":"34","author":"Paice","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2023.05.002_bib0018","unstructured":"NCCN. Adult cancer pain guidelines. guidelines. 2016."},{"issue":"6","key":"10.1016\/j.clbc.2023.05.002_bib0019","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/PPO.0b013e31818f5aa7","article-title":"Management of chronic pain in cancer survivors","volume":"14","author":"Levy","year":"2008","journal-title":"Cancer J"},{"issue":"5","key":"10.1016\/j.clbc.2023.05.002_bib0020","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3109\/0284186X.2014.996662","article-title":"Pain management in cancer survivorship","volume":"54","author":"Kurita","year":"2015","journal-title":"Acta Oncol (Madr)"},{"issue":"8","key":"10.1016\/j.clbc.2023.05.002_bib0021","doi-asserted-by":"crossref","first-page":"977","DOI":"10.6004\/jnccn.2019.0038","article-title":"Adult cancer pain, version 3.2019","volume":"17","author":"Swarm","year":"2019","journal-title":"JNCCN J Natl Compr Cancer Netw"},{"key":"10.1016\/j.clbc.2023.05.002_bib0022","unstructured":"Scott Baker K, Broderick G, Demark-Wahnefried W, et\u00a0al. NCCN guidelines version 2.2020 survivorship NCCN guidelines panel disclosures.; 2020."},{"issue":"11","key":"10.1016\/j.clbc.2023.05.002_bib0023","first-page":"844","article-title":"Pharmacologic management of chronic neuropathic pain review of the Canadian Pain Society Consensus Statement","volume":"63","author":"Mu","year":"2017","journal-title":"Can Fam Physician"},{"issue":"21","key":"10.1016\/j.clbc.2023.05.002_bib0024","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1002\/cncr.30839","article-title":"Cancer survivorship and opioid prescribing rates: a population-based matched cohort study among individuals with and without a history of cancer","volume":"123","author":"Sutradhar","year":"2017","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.clbc.2023.05.002_bib0025","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jpainsymman.2019.02.024","article-title":"Factors associated with opioid use in long-term cancer survivors","volume":"58","author":"Barbera","year":"2019","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clbc.2023.05.002_bib0026","unstructured":"Overview of the SEER program. Available at: https:\/\/seer.cancer.gov\/about\/overview.html. Accessed September 5, 2020."},{"key":"10.1016\/j.clbc.2023.05.002_bib0027","unstructured":"Overview of the SEER program. Available at: https:\/\/seer.cancer.gov\/about\/overview.html. Accessed February 15, 2022."},{"key":"10.1016\/j.clbc.2023.05.002_bib0028","unstructured":"Nih, Nci, DCCPS. Surveillance, epidemiology, and end results (SEER). Available at: https:\/\/seer.cancer.gov. Accessed May 5, 2020."},{"key":"10.1016\/j.clbc.2023.05.002_bib0029","unstructured":"Barbash RB, Brown M, Warren J, Overview of the SEER - medicare data what are the SEER\u2014medicare data\u00a0? 2009."},{"issue":"7","key":"10.1016\/j.clbc.2023.05.002_bib0030","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1158\/1055-9965.EPI-19-1534","article-title":"Medical care costs associated with cancer survivorship in the United States","volume":"29","author":"Mariotto","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clbc.2023.05.002_bib0031","unstructured":"Brief description of SEER-medicare database. Available at: https:\/\/healthcaredelivery.cancer.gov\/seermedicare\/overview\/. Accessed May 18, 2020."},{"issue":"1","key":"10.1016\/j.clbc.2023.05.002_bib0032","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10549-011-1649-1","article-title":"A SEER-medicare population-based study of lymphedema-related claims incidence following breast cancer in men","volume":"130","author":"Reiner","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2023.05.002_bib0033","unstructured":"Available at: https:\/\/www.wellstar.org\/about-us\/icd-10\/documents\/topdiagnosiscodes(crosswalks)all.pdf. Accessed March 29, 2020."},{"issue":"2","key":"10.1016\/j.clbc.2023.05.002_bib0034","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/00000542-200308000-00050","article-title":"Atlas of uncommon pain syndromes","volume":"99","author":"Staats","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1016\/j.clbc.2023.05.002_bib0035","unstructured":"Atlas of common pain syndromes E-Book - Steven D. Waldman\u2014Google books. Available at: https:\/\/books.google.com\/books?id=y794gKjfZGUC&pg=PA68&lpg=PA68&dq=radiation+induced+brachial+plexopathy+diagnosis+code&source=bl&ots=TjpjAeOcM_&sig=ACfU3U0WOIXhKaY0O7S-rolk9A6TRpl9sA&hl=en&sa=X&ved=2ahUKEwjn1uSkm6_oAhUR1qwKHdJlBrM4ChDoATABegQICxAB#v=onepage&q=radiationinducedbrachialplexopathydiagnosiscode&f=false. Accessed March 22, 2020."},{"key":"10.1016\/j.clbc.2023.05.002_bib0036","unstructured":"Complete list of ICD-10-CM medical diagnosis codes. Available at: chrome-extension:\/\/efaidnbmnnnibpcajpcglclefindmkaj\/https:\/\/www.plasticsurgery.org\/Documents\/Health-Policy\/Coding-Payment\/ICD-10\/icd-10-medical-diagnosis-codes.pdf. Accessed June 12 2023."},{"key":"10.1016\/j.clbc.2023.05.002_bib0037","unstructured":"Manchikanti L, Hammer MJ, Boswell M V, Kaye AD, Hirsch JA. Health policy review a seamless navigation to ICD-10-CM for interventional pain physicians: is a rude awakening avoidable? 2015. Available at: www.painphysicianjournal.com. Accessed March 22, 2020."},{"issue":"6 I","key":"10.1016\/j.clbc.2023.05.002_bib0038","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1111\/j.1475-6773.2004.00315.x","article-title":"An algorithm for the use of medicare claims data to identify women with incident breast cancer","volume":"39","author":"Nattinger","year":"2004","journal-title":"Health Serv Res"},{"issue":"2","key":"10.1016\/j.clbc.2023.05.002_bib0039","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.radonc.2015.10.004","article-title":"The impact of radiotherapy costs on clinical outcomes in breast cancer","volume":"117","author":"Boero","year":"2015","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2023.05.002_bib0040","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw178","article-title":"Cost and complications of local therapies for early-stage breast cancer","volume":"109","author":"Smith","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2023.05.002_bib0041","unstructured":"National drug code directory. Available at: https:\/\/www.accessdata.fda.gov\/scripts\/cder\/ndc\/index.cfm. Accessed September 10, 2020."},{"key":"10.1016\/j.clbc.2023.05.002_bib0042","unstructured":"CMS\u2019 ICD-9-CM to and from ICD-10-CM and ICD-10-PCS crosswalk or general equivalence mappings. Available at: http:\/\/data.nber.org\/data\/icd9-icd-10-cm-and-pcs-crosswalk-general-equivalence-mapping.html. Accessed September 9, 2020."},{"issue":"1","key":"10.1016\/j.clbc.2023.05.002_bib0043","first-page":"23","article-title":"Comparison of treatment costs for breast cancer, by tumor stage and type of service","volume":"9","author":"Blumen","year":"2016","journal-title":"Am Heal Drug Benefits"},{"issue":"9","key":"10.1016\/j.clbc.2023.05.002_bib0044","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.2105\/AJPH.2009.160184","article-title":"Timeliness of breast cancer diagnosis and initiation of treatment in the national breast and cervical cancer early detection program, 1996\u20132005","volume":"100","author":"Richardson","year":"2010","journal-title":"Am J Public Health"},{"key":"10.1016\/j.clbc.2023.05.002_bib0045","unstructured":"You've been diagnosed with breast cancer. How soon do you need treatment?\u2014science-based medicine. Available at: https:\/\/sciencebasedmedicine.org\/you-have-breast-cancer-how-soon-do-you-need-treatment\/. Accessed October 12, 2020."},{"issue":"3","key":"10.1016\/j.clbc.2023.05.002_bib0046","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1001\/jamaoncol.2015.3856","article-title":"Delayed initiation of adjuvant chemotherapy among patients with breast cancer","volume":"2","author":"Chavez-MacGregor","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clbc.2023.05.002_bib0047","doi-asserted-by":"crossref","unstructured":"Warren JL, Mariotto A, Melbert D, et\u00a0al. Sensitivity of medicare claims to identify cancer recurrence in elderly colorectal and breast cancer patients. doi:10.1097\/MLR.0000000000000058","DOI":"10.1097\/MLR.0000000000000058"},{"key":"10.1016\/j.clbc.2023.05.002_bib0048","unstructured":"Komen perspectives\u2014what can I expect? Late effects of breast cancer treatment (August 2012) | Susan G. Komen\u00ae. Available at: https:\/\/ww5.komen.org\/KomenPerspectives\/Komen-Perspectives-What-can-I-expect-Late-effects-of-breast-cancer-treatment-(August-2012).html. Accessed October 16, 2020."},{"key":"10.1016\/j.clbc.2023.05.002_bib0049","unstructured":"Coping with long term side effects of treatment. Available at: https:\/\/www.breastcancerfoundation.org.nz\/support\/moving-forward-after-treatment\/coping-with-long-term-side-effects-of-treatment. Accessed October 16, 2020."},{"key":"10.1016\/j.clbc.2023.05.002_bib0050","unstructured":"Learn Oncology. Available at: https:\/\/www.learnoncology.ca\/modules\/breast-cancer. Accessed August 17, 2020."},{"issue":"2","key":"10.1016\/j.clbc.2023.05.002_bib0051","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/cncr.31798","article-title":"Risk of incident claims for chemotherapy-induced peripheral neuropathy among women with breast cancer in a Medicare population","volume":"125","author":"Greenwald","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2023.05.002_bib0052","unstructured":"Drug database | medical device database | FDB (first databank). Available at: https:\/\/www.fdbhealth.com\/. Accessed December 4, 2021."},{"issue":"4","key":"10.1016\/j.clbc.2023.05.002_bib0053","doi-asserted-by":"crossref","first-page":"405","DOI":"10.6004\/jnccn.2019.7373","article-title":"Guideline-concordant treatment among elderly women with HER2-positive metastatic breast cancer in the United States","volume":"18","author":"Vyas","year":"2020","journal-title":"JNCCN J Natl Compr Cancer Netw"},{"issue":"4","key":"10.1016\/j.clbc.2023.05.002_bib0054","doi-asserted-by":"crossref","DOI":"10.1111\/j.1468-0009.2005.00428.x","article-title":"Societal and individual determinants of medical care utilization in the United States","volume":"83","author":"Andersen","year":"2005","journal-title":"Milbank Q"},{"issue":"12","key":"10.1016\/j.clbc.2023.05.002_bib0055","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1097\/MLR.0000000000000822","article-title":"Regional medicare expenditures and survival among older women with localized breast cancer","volume":"55","author":"Tannenbaum","year":"2017","journal-title":"Med Care"},{"issue":"8 Suppl","key":"10.1016\/j.clbc.2023.05.002_bib0056","first-page":"19","article-title":"Patient demographic and socioeconomic characteristics in the SEER-medicare database applications and limitations","volume":"40","author":"Bach","year":"2002","journal-title":"Med Care"},{"issue":"8","key":"10.1016\/j.clbc.2023.05.002_bib0057","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.jtho.2018.04.014","article-title":"Racial-ethnic disparities in end-of-life care quality among lung cancer patients: a SEER-medicare\u2013based study","volume":"13","author":"Karanth","year":"2018","journal-title":"J Thorac Oncol"},{"issue":"12","key":"10.1016\/j.clbc.2023.05.002_bib0058","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.jclinepi.2008.01.006","article-title":"The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients","volume":"61","author":"Charlson","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.clbc.2023.05.002_bib0059","first-page":"102","article-title":"Do formulation and dose of long-term opioid therapy contribute to risk of adverse events among older adults?","author":"Salkar","year":"2021","journal-title":"J Gen Intern Med"},{"issue":"1","key":"10.1016\/j.clbc.2023.05.002_bib0060","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/pm\/pnx009","article-title":"Validation of a screening risk index for serious prescription opioid-induced respiratory depression or overdose in a US commercial health plan claims database","volume":"19","author":"Zedler","year":"2018","journal-title":"Pain Med (United States)"},{"key":"10.1016\/j.clbc.2023.05.002_bib0061","unstructured":"Drug database | medication decision support | FDB (first databank). Available at: https:\/\/www.fdbhealth.com\/. Accessed February 16, 2022."},{"issue":"7","key":"10.1016\/j.clbc.2023.05.002_bib0062","doi-asserted-by":"crossref","first-page":"797","DOI":"10.6004\/jnccn.2020.7659","article-title":"Sociodemographic factors associated with rapid relapse in triple-negative breast cancer: a multi-institution study","volume":"19","author":"Asad","year":"2021","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.clbc.2023.05.002_bib0063","article-title":"Factors associated with 30-days and 180-days psychiatric readmissions: a snapshot of a metropolitan area","volume":"292","author":"Elisa","year":"2020","journal-title":"Psychiatry Res"},{"issue":"6","key":"10.1016\/j.clbc.2023.05.002_bib0064","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1533-2500.2011.00450.x","article-title":"Clinical characteristics, pharmacotherapy, and healthcare resource use among patients with diabetic neuropathy newly prescribed pregabalin or gabapentin","volume":"11","author":"Gore","year":"2011","journal-title":"Pain Pract"},{"issue":"10","key":"10.1016\/j.clbc.2023.05.002_bib0065","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jpain.2006.03.004","article-title":"Factors associated with early opioid prescription among workers with low back injuries","volume":"7","author":"Stover","year":"2006","journal-title":"J Pain"},{"issue":"9","key":"10.1016\/j.clbc.2023.05.002_bib0066","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.6004\/jnccn.2010.0079","article-title":"Chronic pain management in cancer survivors","volume":"8","author":"Mory","year":"2010","journal-title":"JNCCN J Natl Compr Cancer Netw"},{"issue":"30","key":"10.1016\/j.clbc.2023.05.002_bib0067","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1200\/JCO.2013.49.1241","article-title":"Economic burden of cancer survivorship among adults in the United States","volume":"31","author":"Guy","year":"2013","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.clbc.2023.05.002_bib0068","first-page":"2769","article-title":"Cancer treatment-related neuropathic pain: proof of concept study with menthol\u2014a TRPM8 agonist","volume":"23","author":"Fallon","year":"2015","journal-title":"Support Care Cancer"},{"issue":"9","key":"10.1016\/j.clbc.2023.05.002_bib0069","doi-asserted-by":"crossref","first-page":"e777","DOI":"10.1200\/JOP.18.00781","article-title":"Mental health comorbidities and elevated risk of opioid use in elderly breast cancer survivors using adjuvant endocrine treatments","volume":"15","author":"Desai","year":"2019","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.clbc.2023.05.002_bib0070","first-page":"262","article-title":"Variable selection strategies and its importance in clinical prediction modelling","volume":"8","author":"Chowdhury","year":"2020","journal-title":"Fam Med Com Heal"},{"issue":"2","key":"10.1016\/j.clbc.2023.05.002_bib0071","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jpainsymman.2020.08.015","article-title":"Exploring factors associated with long-term opioid therapy in cancer survivors: an integrative review","volume":"61","author":"Jones","year":"2021","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clbc.2023.05.002_bib0072","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pmedr.2017.12.010","article-title":"Outpatient, combined use of opioid and benzodiazepine medications in the United States, 1993\u20132014","volume":"9","author":"Hirschtritt","year":"2018","journal-title":"Prev Med Reports"},{"issue":"1","key":"10.1016\/j.clbc.2023.05.002_bib0073","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3233\/JAD-190787","article-title":"The use of opioids and antipsychotics in elderly with dementia \u2013 have opioids replaced antipsychotics in treating behavioral symptoms in dementia?","volume":"73","author":"Jensen-Dahm","year":"2020","journal-title":"J Alzheimer's Dis"},{"key":"10.1016\/j.clbc.2023.05.002_bib0074","unstructured":"FDA, cder. Neurontin \u00ae (Gabapentin) Capsules Neurontin \u00ae (Gabapentin) Tablets Neurontin \u00ae (Gabapentin) Oral Solution DESCRIPTION."},{"key":"10.1016\/j.clbc.2023.05.002_bib0075","unstructured":"FDA, cder. Highlights of Prescribing Information. Available at: www.fda.gov\/. Accessed June 24, 2020."},{"issue":"10180","key":"10.1016\/j.clbc.2023.05.002_bib0076","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S0140-6736(19)30352-6","article-title":"Transition from acute to chronic pain after surgery","volume":"393","author":"Glare","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.clbc.2023.05.002_bib0077","first-page":"1001","article-title":"Trends in opioid use among older survivors of colorectal, lung, and breast cancers","volume":"37","author":"Salz","year":"2019"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820923001076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820923001076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:25:13Z","timestamp":1761513913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820923001076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":77,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1526820923001076"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2023.05.002","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors Associated With Guideline-Concordant Pharmacological Treatment for Neuropathic Pain Among Breast Cancer Survivors","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2023.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}